ELK3 promotes cisplatin resistance in ovarian cancer via regulating CHD4 gene expression

Qihua Peng1, Kaho Leung1, Yixuan Sun1

  • 1Shanghai Sixth People's Hospital Affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Discover Oncology
|May 19, 2026
PubMed
Abstract

Insights

ELK3 upregulation drives cisplatin resistance in ovarian cancer (OC) by affecting CHD4 and histone lactylation. Targeting the ELK3-CHD4 pathway may overcome chemoresistance in OC patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Cisplatin resistance is a significant challenge in ovarian cancer (OC) treatment.
  • The role of ELK3 (ETS transcription factor) in OC chemoresistance is not well understood.

Purpose of the Study:

  • To investigate the role and molecular mechanisms of ELK3 in OC cisplatin resistance.
  • To explore the ELK3-CHD4-histone lactylation axis as a potential therapeutic target.

Main Methods:

  • Analyzed ELK3 expression in OC cells and tissues (qPCR, Western blotting).
  • Performed functional assays (CCK-8, apoptosis, xenografts) to assess ELK3 impact.
  • Investigated mechanisms using Co-IP and histone lactylation analysis.

Main Results:

  • ELK3 was upregulated in resistant OC tissues/cells, correlating with poor survival.
  • ELK3 knockdown sensitized cells to cisplatin by reducing CHD4 and histone lactylation.
  • Restoring CHD4 rescued cisplatin resistance in ELK3-deficient cells.

Conclusions:

  • The ELK3-CHD4-histone lactylation axis is crucial for OC cisplatin resistance.
  • This pathway represents a potential therapeutic target for overcoming chemoresistance in ovarian cancer.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.